Effectiveness of a Standardized Stroke Upper Limb Rehabilitation Program with Shortened Fugl-Meyer Assessment Stratification
Launched by SALLY HIU LAM WONG · Mar 24, 2025
Trial Information
Current as of July 31, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • first stroke, able to attend gym training and give written consent
- Exclusion Criteria:
- • unstable medical condition, any musculoskeletal conditions or other diseases restricted upper limb training, unfit mental state and unable to follow command
About Sally Hiu Lam Wong
Sally Hiu Lam Wong is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a background in biomedical sciences and extensive experience in project management, she leads initiatives that prioritize ethical standards and regulatory compliance. Her focus on innovative therapies and patient-centric approaches drives her to collaborate with diverse stakeholders, including healthcare professionals, research institutions, and regulatory agencies, ensuring the successful execution of clinical trials. Through her leadership, Sally aims to contribute to the development of groundbreaking treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported